Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes

dc.contributor.authorSánchez Martín, Ma. Jesús
dc.contributor.authorCruz, Antonio
dc.contributor.authorBusquets i Viñas, Ma. Antonia
dc.contributor.authorHaro, Isabel
dc.contributor.authorAlsina Esteller, Ma. Asunción
dc.contributor.authorPujol Cubells, Montserrat
dc.date.accessioned2020-06-04T07:52:38Z
dc.date.available2020-06-04T07:52:38Z
dc.date.issued2012-08
dc.date.updated2020-06-04T07:52:38Z
dc.description.abstractFour peptide sequences corresponding to the E1 protein of GBV-C: NCCAPEDIGFCLEGGCLV (P7), APEDIGFCLEGGCLVALG (P8), FCLEGGCLVALGCTICTD (P10) and QAGLAVRPGKSAAQLVGE (P18) were studied as they were capable of interfering with the HIV-1 fusion peptide (HIV-1 FP). In this work, the surface properties of the E1 peptide sequences are investigated and their physicochemical characterization is done by studying their interaction with model membranes; moreover, their mixtures with HIV-1 FP were also studied in order to observe whether they are capable to modify the HIV-1 FP interaction with model membranes as liposomes or monolayers. Physicochemical properties of peptides (pI and net charge) were predicted showing similarities between P7 and P8, and P10 and HIV-1 FP, whereas P18 appears to be very different from the rest. Circular dichroism experiments were carried out showing an increase of the percentage of α-helix of P7 and P8 when mixed with HIV-1 FP corroborating a conformational change that could be the cause of their inhibition ability. Penetration experiments show that all the peptides can spontaneously insert into phospholipid membranes. Analysis of compression isotherms indicates that the peptides interact with phospholipids and the E1 peptides modify the compression isotherms of HIV-1 FP, but there is one of the peptides that excelled as the best candidate for inhibiting the activity of HIV-1 FP, P7, and therefore, that could be potentially used in future anti-HIV-1 research.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec617951
dc.identifier.issn0378-5173
dc.identifier.urihttps://hdl.handle.net/2445/164194
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.ijpharm.2012.07.051
dc.relation.ispartofInternational Journal of Pharmaceutics, 2012, vol. 436, num. 1-2, p. 593-601
dc.relation.urihttps://doi.org/10.1016/j.ijpharm.2012.07.051
dc.rights(c) Elsevier B.V., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationPèptids
dc.subject.classificationSíntesi de pèptids
dc.subject.classificationVirus de l'hepatitis C
dc.subject.classificationVIH (Virus)
dc.subject.otherPeptides
dc.subject.otherPeptide synthesis
dc.subject.otherHepatitis C virus
dc.subject.otherHIV (Viruses)
dc.titlePhysicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
617951.pdf
Mida:
1.41 MB
Format:
Adobe Portable Document Format